@article {34235,
	title = {Geminin participates in differentiation decisions of adult neural stem cells transplanted in the hemiparkinsonian mouse brain},
	journal = {Stem Cells and Development},
	volume = {26},
	year = {2017},
	pages = {1214-1222},
	publisher = {Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA},
	abstract = {Neural stem cells have been considered as a source of stem cells that can be used for cell replacement therapies in neurodegenerative diseases, as they can be isolated and expanded in vitro and can be used for autologous grafting. However, due to low percentages of survival and varying patterns of differentiation, strategies that will enhance the efficacy of transplantation are under scrutiny. In this article, we have examined whether alterations in Geminin{\textquoteright}s expression, a protein that coordinates the balance between self-renewal and differentiation, can improve the properties of stem cells transplanted in 6-OHDA hemiparkinsonian mouse model. Our results indicate that, in the absence of Geminin, grafted cells differentiating into dopaminergic neurons were decreased, while an increased number of oligodendrocytes were detected. The number of proliferating multipotent cells was not modified by the absence of Geminin. These findings encourage research related to the impact of Geminin on transplantations for neurodegenerative disorders, as an important molecule in influencing differentiation decisions of the cells composing the graft.},
	isbn = {1547-3287},
	url = {https://pubmed.ncbi.nlm.nih.gov/28557659/},
	author = {Taouki, Ioanna and Tasiudi, Eve and Lalioti, Maria-Eleni and Kyrousi, Christina and Skavatsou, Eleni and Kaplani, Konstantina and Lygerou, Zoi and Elias D. Kouvelas and Mitsacos, Adamantia and Panagiotis Giompres and Taraviras, Stavros}
}
